Status:
COMPLETED
COVID-19 in Patients With HIV
Lead Sponsor:
University of Missouri-Columbia
Conditions:
HIV/AIDS
COVID-19
Eligibility:
All Genders
Brief Summary
Currently, limited data is available about patients with HIV in the context of the COVID-19 pandemic. People with HIV who have not achieved viral suppression through antiretroviral treatment may have ...
Detailed Description
Currently, limited data is available about patients with HIV in the context of the COVID-19 pandemic. People with HIV (PWH)/AIDS, or people with HIV who have not achieved viral suppression through ant...
Eligibility Criteria
Inclusion
- HIV disease
- Laboratory-confirmed SARS-CoV-2 infection as determined by polymerase chain reaction (PCR) or other commercial or public health assay
Exclusion
- None
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 28 2022
Estimated Enrollment :
412 Patients enrolled
Trial Details
Trial ID
NCT04333953
Start Date
April 1 2020
End Date
March 28 2022
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri-Columbia
Columbia, Missouri, United States, 65212